340B Report

340B Report is the only subscription-based independent news service that provides breaking news coverage and analysis of the federal 340B drug pricing program. We follow all 340B program developments in federal government agencies, Congress, courts, the states, associations, the private sector, academia, and more. If your success rides on staying on top of the 340B program, 340B Report has you covered. SUBSCRIPTIONS Subscribers receive full access to all 340B Report content--articles, breaking news and news alerts, investigative reports, sponsored content--and exclusive 340B Report hosted webinars. You will receive biweekly newsletters directly in your inbox when new articles are published on our website. To learn more about subscriptions visit https://340breport.com/subscribe/. EDITORIAL The 340B Report editorial team welcomes hearing from 340B program stakeholders. ted.slafsky@340breport.com shannon.young@340breport.com william.newton@340breport.com bella.czajkowski@340breport.com The 340B Report editorial team: Long-time healthcare thought leader and journalist, Publisher and CEO Ted Slafsky Associate Editor and Senior Writer Shannon Young Pharmaceutical industry and health policy reporter, Associate Editor and Senior Writer Will Newton National Correspondent Bella Czajkowski. SPONSORSHIP Sponsorship is a great way to reach key decision-makers at 340B hospitals, health systems, community health centers and other HRSA grantees. Visit https://340breport.com/why-sponsor/ to learn more about all the benefits of 340B Report sponsorship or contact Diane Slafsky at diane.slafsky@340breport.com.